Concepedia

Reduction in doxorubicin toxicity following liposomal delivery

R A Sells, Ian Gilmore, R.R. Owen, Roger New, R. E. Stringer

Cancer Treatment Reviews · 1987 · 15 citations · 2 references

Concepts

PharmacyPharmaceuticsPharmacologyChemotherapyDrug DeliveryPharmacokinetics Of Anticancer AgentsLiposomal FormulationsLiposome-based DeliveryMechanisms Of Toxic InjuryNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanoparticle DesignLiposomal Delivery SystemsLiposomal NanocarriersLiposome Delivery SystemsLiposome Drug DeliveryLiposome Toxicity

References

2

Comparative Long-Term Study of the Toxicities of Free and Liposome-Associated Doxorubicin in Mice After Intravenous Administration<xref ref-type="fn" rid="FN1">2</xref>

Alberto Gabizon, A. Meshorer, Y. Barenholz · JNCI Journal of the National Cancer Institute · 1986 · 114 citations

Pharmacy, Pharmacology, Toxicology +17

Inhibition of Liver Metastases of M 5076 Tumor by Liposome-Entrapped Adriamycin

E. Mayhew, Youcef M. Rustum, William J. Vail · Cancer Drug Delivery · 1983 · 57 citations

Medicine, Oncology, Pharmacology +13